Article
Increased prevalence of clinical and subclinical atherosclerosis in patients with damaging mutations in ABCA1 or APOA1.
Journal of clinical lipidology - 1 Jan 2000
Abdel-Razek Omar, Sadananda Singh N, Li Xuan, Cermakova Lubomira, Frohlich Jiri, Brunham Liam R
Abstract excerpt
BACKGROUND: A low level of high-density lipoprotein cholesterol (HDL-C) is a common clinical scenario and poses challenges for management. Many patients with low HDL-C harbor a damaging mutation in ABCA1 or APOA1, but the clinical implications of genetic testing for these mutations are unclear. OBJECTIVE: The purpose of this study was to investigate the prevalence of clinical or subclinical atherosclerosis among...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
